Anyone with a weakened immune system or external medical device who is exposed to the bacteria faces a risk of serious ...

Reckitt Benckiser Group PLC closed 4.02% short of its 52-week high of £54.18, which the company reached on March 7th.

The U.S. Food and Drug Administration (FDA) is stepping up testing for heavy metals in infant formula and reviewing key ...

The stable outlook reflects Moody’s base case expectations that Reckitt’s gross debt/EBITDA leverage will stay at or below 2.5x, and that the company’s competitive position will continue to support ...

The effort, dubbed “Operation Stork Speed,” aims to ensure “quality, safety, nutritional adequacy, and resilience” of infant ...

RBC Capital analyst James Edwardes Jones maintained a Buy rating on Reckitt (RKT – Research Report) today and set a price target of £57.00. The ...

The FDA would embark on a comprehensive look at the nutrients used in infant formula and increase testing for heavy metals ...

Health and Human Services Secretary Robert F. Kennedy Jr. is planning to meet Tuesday with executives of companies that make ...

Mead Johnson and Abbott Laboratories are to face a new trial in the US over allegations their premature infant formula can ...

Infant formula makers Abbott and Reckitt saw their stocks decline Friday after a judge ruled plaintiffs could pursue a new ...

Missouri 22nd Judicial Circuit Court Judge Michael Noble granted the plaintiff's motion for a new trial on Thursday, citing ...

Reckitt Benckiser said it will appeal the U.S. judge's decision to order a retrial of an infant-formula lawsuit. "Reckitt Shares Drop on Infant Formula Retrial in U.S.," at 14:52 GMT, incorrectly said ...